JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Assembly Biosciences Inc

Closed

SectorHealthcare

23.01 -1.71

Overview

Share price change

24h

Current

Min

22.44

Max

24.33

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.04% upside

Dividends

By Dow Jones

Next Earnings

13 sie 2025

News Sentiment

By Acuity

50%

50%

162 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Assembly Biosciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 gru 2024, 15:25 UTC

Major Market Movers

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding

19 gru 2024, 13:38 UTC

Major Market Movers

Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead

29 gru 2024, 08:00 UTC

Acquisitions, Mergers, Takeovers

Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com

19 gru 2024, 13:23 UTC

Major Market Movers

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead

Peer Comparison

Price change

Assembly Biosciences Inc Forecast

Price Target

By TipRanks

20.04% upside

12 Months Forecast

Average 28.33 USD  20.04%

High 31 USD

Low 25 USD

Based on 3 Wall Street analysts offering 12 month price targets forAssembly Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

11.39 / 14.13Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

162 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

$